All In Biotech

Drug Trial Radar · NCT06915246

A Study of Carmustine With and Without Ethanol in Subjects With Lymphoma

A Randomized Phase 2 Study of Carmustine Formulated With and Without Ethanol as Part of BEAM Chemotherapy Conditioning for Subjects With Lymphoma Undergoing Autologous Hematopoietic Cell Transplantation (AHCT)

Last checked: Nov 19, 2026Latest source record: Mar 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

49

Planned (sponsor's estimate)

Start

Mar 12, 2025

Primary completion

Mar 31, 2027

Study completion Apr 30, 2027

Sponsor

Lead sponsor
VIVUS LLCIndustry
Sponsor type
Industry
First posted
Apr 8, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A phase 2 multicenter study of VI-0609 vs BiCNU in the BEAM high-intensity conditioning regimen for AHCT in subjects with lymphomas.

Conditions

  • Lymphoma
  • Non-Hodgkin Lymphoma
  • Hodgkin Lymphoma

Interventions

  • VI-0609Drug

    Carmustine with Propylene Glycol

  • BiCNUDrug

    Carmustine with Ethanol

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Evaluation of infusion-related toxicitiesTime frame: Within 24 hours post infusion
  2. Evaluation of unacceptable toxicitiesTime frame: From start of BEAM through Day 30 post-AHCT

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • City of Hope Phoenix

    Goodyear, Arizona · Recruiting

  • City of Hope National Medical Center

    Duarte, California · Recruiting

  • City of Hope Atlanta

    Newnan, Georgia · Recruiting

  • City of Hope Chicago

    Zion, Illinois · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.